Spero Therapeutics, Inc. Common Stock
$2.765
USD
Last updated on --.
24h volume578.60K
24h highest2.9000 USD
24h lowest2.7650 USD
24h Price movement-1.95%
SPRO recent prices
24 Hours
-1.95%-$0.055
30 days
+10.78%+$0.275
60 days
+5.81%+$0.155
90 days
+9.07%+$0.235
Key data
Previous close2.8200 USD
Market cap163.28M USD
Volume578.60K
P/E ratio10.720000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.26000 USD
Net income (FY)15.24M USD
Revenue (FY)61.19M USD
Last report dateMay 13, 2026
About Spero Therapeutics, Inc. Common Stock
HeadquartersCAMBRIDGE
Employees (FY)25.00
Revenue per employee (FY)2.45M USD
Net income per employee (FY)609.40K USD
Listed onNasdaq
SPRO conversion tables
 |  |
|---|---|
| 0.5 SPRO | 1.382 USD |
| 1 SPRO | 2.765 USD |
| 5 SPRO | 13.82 USD |
| 10 SPRO | 27.65 USD |
| |
|---|---|
| 0.5 USD | 0.18083 SPRO |
| 1 USD | 0.36166 SPRO |
| 5 USD | 1.808 SPRO |
| 10 USD | 3.616 SPRO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
SPRO is trading at $2.765, -1.95% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SPRO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SPRO is currently trading at $2.765, -1.95% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SPRO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SPRO's P/E ratio is currently 10.720000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SPRO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SPRO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Spero Therapeutics, Inc. Common Stock's market cap is currently 163.28M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume578.60K
24h highest2.9000 USD
24h lowest2.7650 USD
24h Price movement-1.95%
Start trade with SPRO Perpetual
Sign up to trade